BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 28810660)

  • 41. The functional O-mannose glycan on α-dystroglycan contains a phospho-ribitol primed for matriglycan addition.
    Praissman JL; Willer T; Sheikh MO; Toi A; Chitayat D; Lin YY; Lee H; Stalnaker SH; Wang S; Prabhakar PK; Nelson SF; Stemple DL; Moore SA; Moremen KW; Campbell KP; Wells L
    Elife; 2016 Apr; 5():. PubMed ID: 27130732
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Conditional knockout of protein O-mannosyltransferase 2 reveals tissue-specific roles of O-mannosyl glycosylation in brain development.
    Hu H; Li J; Gagen CS; Gray NW; Zhang Z; Qi Y; Zhang P
    J Comp Neurol; 2011 May; 519(7):1320-37. PubMed ID: 21452199
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mammalian O-mannosylation pathway: glycan structures, enzymes, and protein substrates.
    Praissman JL; Wells L
    Biochemistry; 2014 May; 53(19):3066-78. PubMed ID: 24786756
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Deficiency of Dol-P-Man synthase subunit DPM3 bridges the congenital disorders of glycosylation with the dystroglycanopathies.
    Lefeber DJ; Schönberger J; Morava E; Guillard M; Huyben KM; Verrijp K; Grafakou O; Evangeliou A; Preijers FW; Manta P; Yildiz J; Grünewald S; Spilioti M; van den Elzen C; Klein D; Hess D; Ashida H; Hofsteenge J; Maeda Y; van den Heuvel L; Lammens M; Lehle L; Wevers RA
    Am J Hum Genet; 2009 Jul; 85(1):76-86. PubMed ID: 19576565
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ISPD gene mutations are a common cause of congenital and limb-girdle muscular dystrophies.
    Cirak S; Foley AR; Herrmann R; Willer T; Yau S; Stevens E; Torelli S; Brodd L; Kamynina A; Vondracek P; Roper H; Longman C; Korinthenberg R; Marrosu G; Nürnberg P; ; Michele DE; Plagnol V; Hurles M; Moore SA; Sewry CA; Campbell KP; Voit T; Muntoni F
    Brain; 2013 Jan; 136(Pt 1):269-81. PubMed ID: 23288328
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multiple distinct O-Mannosylation pathways in eukaryotes.
    Larsen ISB; Narimatsu Y; Clausen H; Joshi HJ; Halim A
    Curr Opin Struct Biol; 2019 Jun; 56():171-178. PubMed ID: 30999272
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discovery of an O-mannosylation pathway selectively serving cadherins and protocadherins.
    Larsen ISB; Narimatsu Y; Joshi HJ; Siukstaite L; Harrison OJ; Brasch J; Goodman KM; Hansen L; Shapiro L; Honig B; Vakhrushev SY; Clausen H; Halim A
    Proc Natl Acad Sci U S A; 2017 Oct; 114(42):11163-11168. PubMed ID: 28973932
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SGK196 is a glycosylation-specific O-mannose kinase required for dystroglycan function.
    Yoshida-Moriguchi T; Willer T; Anderson ME; Venzke D; Whyte T; Muntoni F; Lee H; Nelson SF; Yu L; Campbell KP
    Science; 2013 Aug; 341(6148):896-9. PubMed ID: 23929950
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Disease mutations in CMP-sialic acid transporter SLC35A1 result in abnormal α-dystroglycan O-mannosylation, independent from sialic acid.
    Riemersma M; Sandrock J; Boltje TJ; Büll C; Heise T; Ashikov A; Adema GJ; van Bokhoven H; Lefeber DJ
    Hum Mol Genet; 2015 Apr; 24(8):2241-6. PubMed ID: 25552652
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population study.
    Mercuri E; Messina S; Bruno C; Mora M; Pegoraro E; Comi GP; D'Amico A; Aiello C; Biancheri R; Berardinelli A; Boffi P; Cassandrini D; Laverda A; Moggio M; Morandi L; Moroni I; Pane M; Pezzani R; Pichiecchio A; Pini A; Minetti C; Mongini T; Mottarelli E; Ricci E; Ruggieri A; Saredi S; Scuderi C; Tessa A; Toscano A; Tortorella G; Trevisan CP; Uggetti C; Vasco G; Santorelli FM; Bertini E
    Neurology; 2009 May; 72(21):1802-9. PubMed ID: 19299310
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of defective glycosylation in congenital muscular dystrophy.
    Schachter H; Vajsar J; Zhang W
    Glycoconj J; 2004; 20(5):291-300. PubMed ID: 15229394
    [TBL] [Abstract][Full Text] [Related]  

  • 52. O-mannosyl glycans: from yeast to novel associations with human disease.
    Willer T; Valero MC; Tanner W; Cruces J; Strahl S
    Curr Opin Struct Biol; 2003 Oct; 13(5):621-30. PubMed ID: 14568618
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Post-translational modification of {alpha}-dystroglycan is not critical for lymphocytic choriomeningitis virus receptor function in vivo.
    Imperiali M; Spörri R; Hewitt J; Oxenius A
    J Gen Virol; 2008 Nov; 89(Pt 11):2713-2722. PubMed ID: 18931067
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comparative study of alpha-dystroglycan glycosylation in dystroglycanopathies suggests that the hypoglycosylation of alpha-dystroglycan does not consistently correlate with clinical severity.
    Jimenez-Mallebrera C; Torelli S; Feng L; Kim J; Godfrey C; Clement E; Mein R; Abbs S; Brown SC; Campbell KP; Kröger S; Talim B; Topaloglu H; Quinlivan R; Roper H; Childs AM; Kinali M; Sewry CA; Muntoni F
    Brain Pathol; 2009 Oct; 19(4):596-611. PubMed ID: 18691338
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulation of mammalian protein O-mannosylation: preferential amino acid sequence for O-mannose modification.
    Manya H; Suzuki T; Akasaka-Manya K; Ishida HK; Mizuno M; Suzuki Y; Inazu T; Dohmae N; Endo T
    J Biol Chem; 2007 Jul; 282(28):20200-6. PubMed ID: 17502374
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Muscular Dystrophy Gene TMEM5 Encodes a Ribitol β1,4-Xylosyltransferase Required for the Functional Glycosylation of Dystroglycan.
    Manya H; Yamaguchi Y; Kanagawa M; Kobayashi K; Tajiri M; Akasaka-Manya K; Kawakami H; Mizuno M; Wada Y; Toda T; Endo T
    J Biol Chem; 2016 Nov; 291(47):24618-24627. PubMed ID: 27733679
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mutations in B3GALNT2 cause congenital muscular dystrophy and hypoglycosylation of α-dystroglycan.
    Stevens E; Carss KJ; Cirak S; Foley AR; Torelli S; Willer T; Tambunan DE; Yau S; Brodd L; Sewry CA; Feng L; Haliloglu G; Orhan D; Dobyns WB; Enns GM; Manning M; Krause A; Salih MA; Walsh CA; Hurles M; Campbell KP; Manzini MC; ; Stemple D; Lin YY; Muntoni F
    Am J Hum Genet; 2013 Mar; 92(3):354-65. PubMed ID: 23453667
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Axl Can Serve as Entry Factor for Lassa Virus Depending on the Functional Glycosylation of Dystroglycan.
    Fedeli C; Torriani G; Galan-Navarro C; Moraz ML; Moreno H; Gerold G; Kunz S
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237830
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dolichol-phosphate mannose synthase depletion in zebrafish leads to dystrophic muscle with hypoglycosylated α-dystroglycan.
    Marchese M; Pappalardo A; Baldacci J; Verri T; Doccini S; Cassandrini D; Bruno C; Fiorillo C; Garcia-Gil M; Bertini E; Pitto L; Santorelli FM
    Biochem Biophys Res Commun; 2016 Aug; 477(1):137-143. PubMed ID: 27291147
    [TBL] [Abstract][Full Text] [Related]  

  • 60. LARGE can functionally bypass alpha-dystroglycan glycosylation defects in distinct congenital muscular dystrophies.
    Barresi R; Michele DE; Kanagawa M; Harper HA; Dovico SA; Satz JS; Moore SA; Zhang W; Schachter H; Dumanski JP; Cohn RD; Nishino I; Campbell KP
    Nat Med; 2004 Jul; 10(7):696-703. PubMed ID: 15184894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.